Clinical trials
Recruiting Neoplasms trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
492 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 7 |
| 2019 | 11 |
| 2020 | 9 |
| 2021 | 13 |
| 2022 | 42 |
| 2023 | 58 |
| 2024 | 86 |
| 2025 | 145 |
| 2026 | 100 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 492 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut du Cancer de Montpellier - Val d'Aurelle | 14 |
| M.D. Anderson Cancer Center | 9 |
| The University of Hong Kong | 8 |
| Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | 6 |
| University of Rochester | 6 |
| Chinese University of Hong Kong | 5 |
| Dana-Farber Cancer Institute | 5 |
| Hospices Civils de Lyon | 5 |
| Imperial College London | 5 |
| Institut Curie | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 492 |
| Breast Neoplasms | 39 |
| Colorectal Neoplasms | 21 |
| Lung Neoplasms | 18 |
| Colonic Neoplasms | 16 |
| Neoplasm Metastasis | 14 |
| Prostatic Neoplasms | 14 |
| Head and Neck Neoplasms | 13 |
| Lymphoma | 11 |
| Anxiety Disorders | 10 |
Trials
Showing 1 to 25 of 492. Each trial links to its page on Pharma Observatory.
392 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.